This inventor holds 28 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Immunomodulatory Agents. Top assignees: Bristol-Myers Squibb Compnay, Flexus Biosciences, Inc., Syngene International Limited. Active years: 2006-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
24 out of 3,742 
5 out of 8 
1 out of 7 
Years Active: 2006-2024
Areas of Expertise:
Title: The Innovative Contributions of Weifang Shan: A Journey in Patent Development
Introduction: Weifang Shan, based in Princeton, NJ, is a renowned inventor with an impressive portfolio of 28 patents. His groundbreaking work primarily focuses on the development of inhibitors for medical use, particularly in treating proliferative disorders such as cancer.
Latest Patents: Among his notable patents, Weifang Shan has developed compounds designed as inhibitors of indoleamine 2,3-dioxygenase (IDO). These compounds, defined by the specific formula (I), hold the potential to serve as effective medicaments for various serious health conditions, including cancer, viral infections, and autoimmune diseases. The innovative approach showcased in these patents underscores the critical importance of IDO inhibitors in expanding treatment options for challenging medical conditions.
Career Highlights: Throughout his career, Weifang Shan has made significant strides in pharmaceutical development. He has had the privilege of working with prestigious companies, including Bristol-Myers Squibb Company and Flexus Biosciences, Inc. His experience in these organizations has provided him with a strong foundation in the industry, aiding in the advancement of his innovative ideas into viable medical solutions.
Collaborations: Collaboration has been a key aspect of Weifang Shan's journey. He has had the opportunity to work with esteemed colleagues, including James Aaron Balog and David K. Williams. Together, they have contributed to the creation and refinement of impactful medical therapies, showcasing the importance of teamwork in scientific innovation.
Conclusion: Weifang Shan's contributions to the field of immunology and cancer treatment are invaluable. With his extensive patent portfolio and collaborative spirit, he continues to pave the way for innovative therapies that hold promise for numerous patients facing proliferative disorders. His work exemplifies the power of inventions in transforming the landscape of medical treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile